Cyclin-dependent kinase inhibitors: novel anticancer agents

Author： Mani S. Wang C. Wu K. Francis R. Pestell R.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.8, 2000-08, pp. : 1849-1870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 291-302

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic inhibitors of yeast cyclin-dependent kinase-activating kinases as antifungal agents

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 925-927

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Cyclin-Dependent Kinases as Anti-Cancer Therapeutics

Current Medicinal Chemistry, Vol. 7, Iss. 12, 2000-12 ,pp. : 1213-1245

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors closer to market launch?

By Galons Hervé

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 945-963

Informa Healthcare

Access to resources Recommend Favorite